ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,07695
-0,32%
Bitcoin
69.728,48
0,61%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Kalvista Pharmaceuticals (MM) (CBYL)

  7. Kalvista Pharmaceuticals (MM) (CBYL) News

CBYL

CARBYLAN THERAPEUTICS, INC. (CBYL)

Kalvista Pharmaceuticals (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CBYL
DatumZeitQuelleÜberschriftSymbolFirma
30/11/201622h25Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
30/11/201622h16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
23/11/201623h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
23/11/201619h36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
22/11/201622h15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
22/11/201622h15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
21/11/201622h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
08/11/201622h18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
04/11/201621h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
28/10/201612h11Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
26/10/201622h17Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
30/09/201622h59Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
30/09/201622h10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
23/09/201613h53PR Newswire (US)Carbylan Shareholder (CBYL) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues its Investigation of Carbylan...NASDAQ:CBYLKalvista Pharmaceuticals (MM)
12/09/201619h38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
24/08/201612h02Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
12/08/201622h19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
29/07/201622h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
28/06/201622h13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
27/06/201623h21Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
24/06/201622h21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
24/06/201622h19Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
24/06/201622h18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
23/06/201623h30Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
22/06/201622h48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
22/06/201622h46Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
22/06/201622h00GlobeNewswire Inc.Carbylan Therapeutics and KalVista Pharmaceuticals Conference Call to Discuss Proposed TransactionNASDAQ:CBYLKalvista Pharmaceuticals (MM)
17/06/201612h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
15/06/201613h53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
15/06/201613h51Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:CBYL

Kürzlich von Ihnen besucht

NASDAQ
QQQ
Invesco QQQ Trust Series 1
TG
TUI1
Tui
NYSE
MRK
Merck
TG
LHA
Deutsche Lufthansa
COIN
BTCUSD
Bitcoin
TG
BAYN
Bayer
USOTC
ADDYY
Adidas (QX)
TG
D7G
Nel ASA
NASDAQ
AAPL
Apple
COIN
SOLUSD
Solana
USOTC
RHHBY
Roche (QX)
TG
CBK
Commerzbank
AMEX
XLF
Financial Select Sector
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten